跳至主要内容
临床试验/NCT00880958
NCT00880958已完成不适用

Effects of Supplement Containing Various Probiotics and Fermentation Products on Obesity: a Double-Blind, Randomized Controlled Trial

Hiroshima University2 个研究点 分布在 1 个国家目标入组 30 人开始时间: 2009年3月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
30
试验地点
2
主要终点
Body mass index

研究概览

简要总结

The purpose of this study is to determine the effect of supplement combined various probiotics and fermentation products on body mass index, body fat mass, abdominal circumference, visceral fat mass, intestinal flora, and serum biochemical parameters in overweight subjects.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
Double (Participant, Outcomes Assessor)

入排标准

年龄范围
20 Years 至 70 Years(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • Healthy as based on medical history and physical examination
  • BMI between 25 and 30 kg/m2
  • Willing not to serve as blood donor during the study
  • Informed consent signed

排除标准

  • Food allergy
  • Female subjects who are pregnant or nursing a child
  • Participation in any clinical trial up to 90 days before Day 01 of this study
  • Renal or hepatic dysfunction
  • Heart disease
  • Under medication
  • Subjects who are taking functional food designed for weight loss or serum lipid reduction

结局指标

主要结局

Body mass index

时间窗: 16 weeks

次要结局

  • Body fat mass(Week -4, Week 0, Week 4, Week 12)
  • Abdominal circumference(Week -4, Week 0, Week 4, Week 12)
  • Visceral fat area by CT scan(Week 0, Week 12)
  • Intestinal flora(Week 0, Week 12)
  • Serum lipid profile(Week -4, Week 0, Week 4, Week 12)
  • Serum adiponectin and leptin levels(Week 0, Week 12)
  • Fasting serum glucose and HbA1c levels(Week -4, Week 0, Week 4, Week 12)

研究者

申办方类型
Other

研究点 (2)

Loading locations...

相似试验